312 related articles for article (PubMed ID: 25869301)
1. Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus.
Thakkar UG; Trivedi HL; Vanikar AV; Dave SD
Cytotherapy; 2015 Jul; 17(7):940-7. PubMed ID: 25869301
[TBL] [Abstract][Full Text] [Related]
2. Novel therapy for insulin-dependent diabetes mellitus: infusion of in vitro-generated insulin-secreting cells.
Dave SD; Vanikar AV; Trivedi HL; Thakkar UG; Gopal SC; Chandra T
Clin Exp Med; 2015 Feb; 15(1):41-5. PubMed ID: 24317657
[TBL] [Abstract][Full Text] [Related]
3. Co-infusion of autologous adipose tissue derived insulin-secreting mesenchymal stem cells and bone marrow derived hematopoietic stem cells: viable therapy for type III.C. a diabetes mellitus.
Thakkar UG; Vanikar AV; Trivedi HL
Biomed J; 2013; 36(6):304-7. PubMed ID: 24385073
[TBL] [Abstract][Full Text] [Related]
4. Human adipose tissue-derived mesenchymal stem cells combined with hematopoietic stem cell transplantation synthesize insulin.
Trivedi HL; Vanikar AV; Thakker U; Firoze A; Dave SD; Patel CN; Patel JV; Bhargava AB; Shankar V
Transplant Proc; 2008 May; 40(4):1135-9. PubMed ID: 18555133
[TBL] [Abstract][Full Text] [Related]
5. C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.
Couri CE; Oliveira MC; Stracieri AB; Moraes DA; Pieroni F; Barros GM; Madeira MI; Malmegrim KC; Foss-Freitas MC; Simões BP; Martinez EZ; Foss MC; Burt RK; Voltarelli JC
JAMA; 2009 Apr; 301(15):1573-9. PubMed ID: 19366777
[TBL] [Abstract][Full Text] [Related]
6. Combined therapy of insulin-producing cells and haematopoietic stem cells offers better diabetic control than only haematopoietic stem cells' infusion for patients with insulin-dependent diabetes.
Dave SD; Trivedi HL; Gopal SC; Chandra T
BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25199184
[TBL] [Abstract][Full Text] [Related]
7. Investigating the safety and efficacy of hematopoietic and mesenchymal stem cell transplantation for treatment of T1DM: a systematic review and meta-analysis.
Madani S; Amanzadi M; Aghayan HR; Setudeh A; Rezaei N; Rouhifard M; Larijani B
Syst Rev; 2022 May; 11(1):82. PubMed ID: 35501872
[TBL] [Abstract][Full Text] [Related]
8. Management of type 1 diabetes mellitus using in vitro autologous adipose tissue trans-differentiated insulin-making cells.
Dave SD; Trivedi HL; Chooramani SG; Chandra T
BMJ Case Rep; 2013 Jul; 2013():. PubMed ID: 23893283
[TBL] [Abstract][Full Text] [Related]
9. Allogenic Adipose Tissue-Derived Stromal/Stem Cells and Vitamin D Supplementation in Patients With Recent-Onset Type 1 Diabetes Mellitus: A 3-Month Follow-Up Pilot Study.
Araujo DB; Dantas JR; Silva KR; Souto DL; Pereira MFC; Moreira JP; Luiz RR; Claudio-Da-Silva CS; Gabbay MAL; Dib SA; Couri CEB; Maiolino A; Rebelatto CLK; Daga DR; Senegaglia AC; Brofman PRS; Baptista LS; Oliveira JEP; Zajdenverg L; Rodacki M
Front Immunol; 2020; 11():993. PubMed ID: 32582156
[No Abstract] [Full Text] [Related]
10. Umbilical Cord Mesenchymal Stromal Cell With Autologous Bone Marrow Cell Transplantation in Established Type 1 Diabetes: A Pilot Randomized Controlled Open-Label Clinical Study to Assess Safety and Impact on Insulin Secretion.
Cai J; Wu Z; Xu X; Liao L; Chen J; Huang L; Wu W; Luo F; Wu C; Pugliese A; Pileggi A; Ricordi C; Tan J
Diabetes Care; 2016 Jan; 39(1):149-57. PubMed ID: 26628416
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus: a randomized placebo-controlled study.
Bhansali A; Asokumar P; Walia R; Bhansali S; Gupta V; Jain A; Sachdeva N; Sharma RR; Marwaha N; Khandelwal N
Cell Transplant; 2014; 23(9):1075-85. PubMed ID: 23561959
[TBL] [Abstract][Full Text] [Related]
12. Co-infusion of adipose tissue derived mesenchymal stem cell-differentiated insulin-making cells and haematopoietic cells with renal transplantation: a novel therapy for type 1 diabetes mellitus with end-stage renal disease.
Dave SD; Vanikar AV; Trivedi HL
BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23709153
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of autologous stem cell transplantation for the treatment of patients with type 2 diabetes mellitus: a meta-analysis.
Wang ZX; Cao JX; Li D; Zhang XY; Liu JL; Li JL; Wang M; Liu Y; Xu BL; Wang HB
Cytotherapy; 2015 Jul; 17(7):956-68. PubMed ID: 25824289
[TBL] [Abstract][Full Text] [Related]
14. Treatment of polyglandular autoimmune syndrome type 3 using co-transplantation of insulin-secreting mesenchymal stem cells and haematopoietic stem cells.
Trivedi HL; Thakkar UG; Vanikar AV; Dave SD
BMJ Case Rep; 2011 Sep; 2011():. PubMed ID: 22679189
[TBL] [Abstract][Full Text] [Related]
15. Co-infusion of autologous adipose tissue derived neuronal differentiated mesenchymal stem cells and bone marrow derived hematopoietic stem cells, a viable therapy for post-traumatic brachial plexus injury: a case report.
Thakkar UG; Vanikar AV; Trivedi HL
Biomed J; 2014; 37(4):237-40. PubMed ID: 25116721
[TBL] [Abstract][Full Text] [Related]
16. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.
Voltarelli JC; Couri CE; Stracieri AB; Oliveira MC; Moraes DA; Pieroni F; Coutinho M; Malmegrim KC; Foss-Freitas MC; Simões BP; Foss MC; Squiers E; Burt RK
JAMA; 2007 Apr; 297(14):1568-76. PubMed ID: 17426276
[TBL] [Abstract][Full Text] [Related]
17. Co-infusion of donor adipose tissue-derived mesenchymal and hematopoietic stem cells helps safe minimization of immunosuppression in renal transplantation - single center experience.
Vanikar AV; Trivedi HL; Kumar A; Gopal SC; Patel HV; Gumber MR; Kute VB; Shah PR; Dave SD
Ren Fail; 2014 Oct; 36(9):1376-84. PubMed ID: 25246338
[TBL] [Abstract][Full Text] [Related]
18. Cotransplantation of adipose tissue-derived insulin-secreting mesenchymal stem cells and hematopoietic stem cells: a novel therapy for insulin-dependent diabetes mellitus.
Vanikar AV; Dave SD; Thakkar UG; Trivedi HL
Stem Cells Int; 2010 Dec; 2010():582382. PubMed ID: 21197448
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cell and Mononuclear Cell Transplantation in Type 2 Diabetes Mellitus: A Randomized, Placebo-Controlled Comparative Study.
Bhansali S; Dutta P; Kumar V; Yadav MK; Jain A; Mudaliar S; Bhansali S; Sharma RR; Jha V; Marwaha N; Khandelwal N; Srinivasan A; Sachdeva N; Hawkins M; Bhansali A
Stem Cells Dev; 2017 Apr; 26(7):471-481. PubMed ID: 28006991
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus.
Bhansali A; Upreti V; Khandelwal N; Marwaha N; Gupta V; Sachdeva N; Sharma RR; Saluja K; Dutta P; Walia R; Minz R; Bhadada S; Das S; Ramakrishnan S
Stem Cells Dev; 2009 Dec; 18(10):1407-16. PubMed ID: 19686048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
